No Data
CORRECTION: BioMarin Pharmaceutical Ticker Is "BMRN"
CORRECTION: BioMarin Pharmaceutical Ticker Is "BMRN"
LifeStance Health Gains as Hedgeye Adds as New Long Idea
Piper Sandler Reiterates Overweight on Definium Therapeutics, Raises Price Target to $75
Piper Sandler analyst David Amsellem reiterates Definium Therapeutics (NASDAQ:DFTX) with a Overweight and raises the price target from $73 to $75.
HC Wainwright & Co. Maintains Neutral on BioMarin Pharmaceutical, Raises Price Target to $60
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains BioMarin Pharmaceutical (NASDAQ:BMRN) with a Neutral and raises the price target from $50 to $60.
BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16
BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.
Haseko, ZOZO, and Others (Added) Rating
Upgrades - Bullish Code Stock Name Brokerage Previous Revised------------------------------------------------------------<4188> Mitsubishi Chemical GSBI "Neutral" "Buy" <4483> JMDC Tokai Tokyo "Neutral" "Outperform" Downgrades - Bearish Code Stock Name Brokerage Previous Revised-----------------------------------------------